Skip to main content
. 2002 Apr 27;324(7344):999. doi: 10.1136/bmj.324.7344.999

Table 4.

Comparison of the two randomised groups over subsequent year. Values are numbers (percentages) unless stated otherwise

Endoscopy plus breath test (n=292) Breath test alone (n=294)
Mean (SD; range) Glasgow dyspepsia severity score 5.4 (3.4; 0-15) 5.6 (3.4; 0-15)
Frequency of:
 Visit to general practitioner for dyspepsia 98/292 (34) 108/293 (37)
 Attendance at hospital outpatient clinic for dyspepsia 19/292 (7) 18/293 (6)
 Endoscopy 4/292 (1) 24/294 (8)
 Repeat breath test (in patients testing positive on entry) 27/292 (9) (26/156 (17)) 19/294 (6) (18/142 (13))
 Barium meal 5/292 (2) 1/294 (0.3)
 Ultrasonography 3/292 (1) 10/294 (3)
 Other gastrointestinal investigations 11/292 (4) 7/294 (2)
Drug usage (% treated) (median length of treatment):
 Proton pump inhibitor 69/291 (24) (24 weeks) 77/292 (26) (20 weeks)
 H2 receptor antagonist 56/291 (19) (10 weeks) 68/293 (23) (20 weeks)
 Antacids 82/291 (28) (18 weeks) 90/293 (31) (10 weeks)
 Alginates 73/290 (25) (12 weeks) 82/291 (28) (6 weeks)
Patient oriented outcomes (0-10: 0=no concern, 10=extreme concern)
 Mean (SD; range) overall concern about symptoms 2.4 (2.6, 0-10) 2.4 (2.4; 0-10)
 Mean (SD; range) concern about missed disease 1.7 (2.3; 0-10) 1.9 (2.5; 0-10)
 Mean (SD; range) overall satisfaction with management  8.9 (1.6; 0.8-10) 8.9 (1.7; 0-10)